Sandusky, OH, Sept. 24, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s partnership with Puration, Inc. (OTC Pink: PURA).
PAOG is developing CBD pharmaceutical and nutraceuticals from its intellectual property associated with a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."
PAOG recently announced plans to launch a CBD nutraceuticals line of products expected to generate revenue this year, in 2021.
PURA has launched a hemp industry wide strategic initiative to collectively market for multiple hemp growers and processors under a single brand name - Farmersville Hemp.
PURA is building processing and cultivation partners with the intention of establishing an industrial hemp brand cooperative under the Farmersville Hemp Brand name. In the fashion that Sun-Maid Raisins collectively markets for growers all selling under one brand name, PURA plans to collectively market for multiple hemp growers and processors under the Farmersville Hemp Brand name.
PAOG is one of PURA’s first partners in PURA’s Farmersville Hemp Brand Initiative.
PAOG and PURA intend to work specifically together on a cannabis extraction lab to be included on PURA’s 70-acre property in Farmersville Texas.
PURA recently broke ground on its 70-acre property in Farmersville Texas. A construction pad has been cleared for the building of multiple buildings where PURA will facilitate hands on marketing for a wide variety of products that can be derived from hemp.
The Farmersville Hemp Brand Facility will be able to host client companies for seminars to demonstrate hemp processing and how hemp can be used as a natural, cost effective and even superior alternative to currently available construction materials, nutraceuticals and pharmaceuticals, clothing, fuel, and plastics - to name just a few. According to one source, more than 25,000 products can be made from hemp.
PAOG’s CBD nutraceutical developments stem from the company’s long-term CBD pharmaceutical initiative built on a CBD intellectual property acquisition from Nouveau Life Pharmaceuticals (OTC Pink: NOUV).
The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion, and it is expected to reach $16.4 Billion by 2027.
Learn more about PAOG at www.paogroupinc.com.
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
CONTACT INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
info@pao.group
